Condition: Peripheral Arterial Hemorrhage · Trauma · GI Bleed · Sponsor: Medtronic Endovascular
The purpose of this study is to evaluate the safety and effectiveness of Onyx™ LES in the treatment of subjects with active arterial bleeding in the peripheral vasculature outside of the heart and brain.
This description comes directly from the study's public registry record.
Janki Shah · 7322662503 · janki.shah@medtronic.com
Liza Marie · 7072172314 · liza.marie@medtronic.com
Always discuss trial participation with your own doctor first.
| Mayo Clinic | Phoenix, Arizona, United States | Recruiting |
| University of California, Irvine | Irvine, California, United States | Recruiting |
| Stanford Medical Center | Palo Alto, California, United States | Recruiting |
| UCHealth University of Colorado Hospital | Aurora, Colorado, United States | Recruiting |
| Yale New Haven | New Haven, Connecticut, United States | Recruiting |
| University of Chicago | Chicago, Illinois, United States | Recruiting |
| University of Iowa Hospitals and Clinics | Iowa City, Iowa, United States | Recruiting |
| Masschusetts General Hospital | Boston, Massachusetts, United States | Recruiting |
| CHI Health Creighton University Medical Center-Bergan-Mercy | Omaha, Nebraska, United States | Recruiting |
| Rutgers New Jersey Medical School | Newark, New Jersey, United States | Suspended |
| Albany Medical Center | Albany, New York, United States | Recruiting |
| The Mount Sinai | New York, New York, United States | Recruiting |
+ 6 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06742801